Clinical Trials Directory

Trials / Completed

CompletedNCT04364854

Speech Entrainment for Aphasia Recovery

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
21 Years – 81 Years
Healthy volunteers
Not accepted

Summary

After a stroke, many people experience a language impairment called aphasia. One of the most debilitating types of aphasia is non-fluent aphasia. Non-fluent aphasia is defined by significantly reduced speech production, with the speaker producing only a few words or even less. Speech entrainment therapy (SET) is a treatment that has been shown to increase fluency in people with non-fluent aphasia. The study looks to define the best dose of SET that leads to sustained improvements in spontaneous speech production. Participants who are eligible will undergo baseline language testing, an MRI, and will be randomized into one of 4 treatment groups: SET for 3 weeks, SET for 4.5 weeks, SET for 6 weeks, and no treatment (control group).

Conditions

Interventions

TypeNameDescription
BEHAVIORALSET (Speech Entrainment Therapy) 3 weeks3 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
BEHAVIORALSET (Speech Entrainment Therapy) 4.5 weeks4.5 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
BEHAVIORALSET (Speech Entrainment Therapy) 6 weeks6 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
OTHERNo Therapy 6 WeeksParticipants will not be getting any SET for 6 weeks

Timeline

Start date
2020-08-21
Primary completion
2024-05-08
Completion
2025-08-31
First posted
2020-04-28
Last updated
2025-11-14
Results posted
2025-04-01

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04364854. Inclusion in this directory is not an endorsement.